Sernova Biotherapeutics Inc
SEOVF
$0.1219
$0.00141.16%
OTC PK
| 04/30/2025 | 01/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -11.22% | 8.13% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -9.88% | -1.52% | |||
| Operating Income | 9.88% | 1.52% | |||
| Income Before Tax | 34.26% | -10.18% | |||
| Income Tax Expenses | 475.56% | -11.76% | |||
| Earnings from Continuing Operations | 33.69% | -10.14% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 33.69% | -10.14% | |||
| EBIT | 9.88% | 1.52% | |||
| EBITDA | 9.98% | -0.47% | |||
| EPS Basic | 33.61% | -6.09% | |||
| Normalized Basic EPS | 34.21% | -5.56% | |||
| EPS Diluted | 33.61% | -6.09% | |||
| Normalized Diluted EPS | 34.21% | -5.56% | |||
| Average Basic Shares Outstanding | 0.31% | 3.15% | |||
| Average Diluted Shares Outstanding | 0.31% | 3.15% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||